Arriving in the landscape of obesity therapy, retatrutide website presents a unique method. Unlike many existing medications, retatrutide operates as a dual agonist, at once targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. This concurrent stimulation encourages various beneficial effects, includ